Shares Issued
As at 7 February 2020, the number of shares in issue was 397,253,969.
Significant Shareholders
As at 7 February 2020
| Shareholder | Number | Ordinary Shares % |
|---|---|---|
| Craig Auringer | 31,407,913 | 7.91 |
| Samantha Bauer | 17,996,487 | 4.53 |
| Ron Valk | 17,131,193 | 4.31 | Mark Hawtin | 13,268,570 | 3.34 |
Director Shareholdings
As at 7 February 2020
| Director | Number | Ordinary Shares % |
|---|---|---|
| Alexis Sandler | 75,090,685 | 18.90 |
| Dr Vladislav Sandler | 41,544,677 | 10.46 |
| Peter Redmond | 5,596,270 | 1.41 |
Shares Not In Public Hands
Insofar as it is aware, as at 7 February 2020, 56.32% of the Company’s securities were not in public hands.
UK City Code On Takeovers And Mergers
The Company is subject to the provisions of the City Code on Takeovers and Mergers.
Shareholder Circulars
| 28 May 2019 | Notice of AGM to held on 28 June 2019 |
Other Exchanges And Trading Platforms
Hemogenyx Pharmaceuticals plc has not applied or agreed to have any of it securities admitted or traded on any other exchanges or trading platforms.